Vetoes of Defense Authorization Bills, and More from CRS
If President Obama vetoes the pending FY2016 defense authorization bill, “it would mark the fifth time since 1961, when Congress enacted the first annual defense authorization bill, that a president has vetoed that measure,” according to the Congressional Research Service. See Presidential Vetoes of Annual Defense Authorization Bills, CRS Insight, October 1, 2015.
New and updated publications from the Congressional Research Service that were issued in the past week include the following.
Overview of the FY2016 Continuing Resolution (H.R. 719), October 1, 2015
Public Health Service Agencies: Overview and Funding (FY2010-FY2016), updated October 2, 2015
DHS Appropriations FY2016: Security, Enforcement and Investigations, October 2, 2015
Poland and Its Relations with the United States: In Brief, September 30, 2015
State, Foreign Operations, and Related Programs: FY2016 Budget and Appropriations, updated October 1, 2015
U.S. Agricultural Trade with Cuba: Current Limitations and Future Prospects, updated October 1, 2015
How Treasury Issues Debt, updated October 1, 2015
Disconnected Youth: A Look at 16 to 24 Year Olds Who Are Not Working or In School, updated October 1, 2015
Kuwait: Governance, Security, and U.S. Policy, updated October 1, 2015
Yemen: Civil War and Regional Intervention, updated October 2, 2015
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.